1. Home
  2. DK vs NVCR Comparison

DK vs NVCR Comparison

Compare DK & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Delek US Holdings Inc.

DK

Delek US Holdings Inc.

HOLD

Current Price

$45.18

Market Cap

1.8B

Sector

Energy

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$10.59

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DK
NVCR
Founded
2001
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Integrated oil Companies
Medical/Dental Instruments
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.5B
IPO Year
2017
2015

Fundamental Metrics

Financial Performance
Metric
DK
NVCR
Price
$45.18
$10.59
Analyst Decision
Hold
Buy
Analyst Count
17
6
Target Price
$36.94
$28.08
AVG Volume (30 Days)
1.3M
1.0M
Earning Date
05-06-2026
04-30-2026
Dividend Yield
2.27%
N/A
EPS Growth
95.67
21.79
EPS
N/A
N/A
Revenue
N/A
$655,353,000.00
Revenue This Year
$0.50
$7.72
Revenue Next Year
$0.58
$6.74
P/E Ratio
N/A
N/A
Revenue Growth
N/A
8.28
52 Week Low
$11.07
$9.82
52 Week High
$48.32
$20.05

Technical Indicators

Market Signals
Indicator
DK
NVCR
Relative Strength Index (RSI) 58.55 38.22
Support Level $36.00 N/A
Resistance Level $48.32 $14.11
Average True Range (ATR) 2.51 0.56
MACD -0.31 -0.13
Stochastic Oscillator 54.19 13.15

Price Performance

Historical Comparison
DK
NVCR

About DK Delek US Holdings Inc.

Delek US Holdings Inc is an integrated energy business focused on petroleum refining, transportation and storage; wholesale crude oil, intermediate, and refined products, and convenience stores retailing. The company owns and operates independent refineries that produce a variety of petroleum products for transportation and industrial markets in the United States. It has two segments: Refining segment and Logistics segment. The logistics segment generates revenue through gathering, transporting, and storing crude oil and intermediate products, as well as by marketing, storing, and distributing refined products. The company also offers a collection of retail fuel and convenience stores operating in the Southeast region of the United States.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

Share on Social Networks: